Gland Pharma Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Gland Pharma Receives Approval for Zoledronic Acid Injection, 4 mg/100 mL (0.04 mg/ mL) Single-Dose Bags".
Press Release Feb 06 2026
Earlier from Gland Pharma
- Press Release Jan 28 2026
- Press Release Jan 07 2026
- Press Release Nov 03 2025
- Press Release Aug 26 2025